Unnecessary Psychoactive Medication Use Without Clinical Justification
Summary
The facility failed to document clinical justification for continued psychoactive medication use for two sampled residents, Resident 5 and Resident 18, despite its policy requiring psychotropic medications to be clinically indicated, supported by a written explanation in the medical record, and paired with gradual dose reductions unless contraindicated. The policy also required non-pharmacological interventions and documentation of the rationale when a dose reduction was not attempted or when other psychotropics were continued or adjusted. Resident 5 had diagnoses including unspecified dementia with severe mood disturbance and bipolar disorder, and a BIMS score of 3 indicating significant cognitive impairment. Observations in December 2025 showed the resident seated in a wheelchair, not verbalizing, not responding to questions, and later not alert and unable to feed herself or propel her wheelchair. The resident had been receiving Ziprasidone HCL 40 mg twice daily since December 2021, but the record showed no behaviors from August through December 2025 to support continued use. Psychiatric evaluations documented the resident as confused but calm and cooperative, with stable mood, no sleep or appetite changes, and no psychosis. Although a note stated a gradual dose reduction was considered contraindicated due to potential for increased symptoms, the record did not include additional clinical reasoning, updated assessment, therapeutic goals, or evidence of non-pharmacological interventions to support continuing the medication at the current dose. Resident 18 had diagnoses including unspecified psychosis, recurrent depressive disorders, anxiety, and unspecified dementia with agitation, and was prescribed multiple psychoactive medications including Sertraline, Lorazepam, and Quetiapine. The consultant pharmacist documented that CMS expects routine review of psychoactive medications and consideration of a gradual dose reduction unless there is documented medical reasoning that a reduction is not appropriate, and requested clinical rationale if a GDR could not be attempted. The prescriber disagreed with a GDR and stated the resident continued with occasional symptoms, but the record did not identify current symptoms, treatment goals, non-pharmacological interventions, or documentation showing why a dose reduction would be unsafe or medically contraindicated. No additional documentation was provided to support the continued regimen.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.